Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Can Cannabis Increase Risk of Dependency in OSA Patients? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Using cannabis in patients with obstructive sleep apnoea (OSA)  carries potential risks, including the development of cannabis dependency in OSA. Understanding these risks is crucial for safe and effective management. 

Am I eligible for medical cannabis for pain relief?

Risk Factors for Dependency 

Chronic use of cannabis can sometimes lead to cannabis dependency in OSA, particularly in patients using it regularly for sleep or symptom management. Awareness of cannabis misuse in OSA helps clinicians identify patients at higher risk. 

Frequency and Dosage 

Frequent or high-dose cannabis use increases the likelihood of cannabis dependency in OSA, making careful dosing essential. 

Patient Vulnerabilities 

Individual factors such as history of substance use or mental health conditions can elevate cannabis’ addiction risk, requiring closer monitoring. 

Monitoring and Prevention 

Early recognition of cannabis misuse in OSA allows interventions to reduce the risk of dependency. Clinicians should provide guidance on safe use, dosing, and alternatives to support responsible consumption. 

Understanding cannabis dependency in OSA is key to minimising potential harms. Considering cannabis misuse in OSA and cannabis’ addiction risk ensures that cannabis therapy remains a helpful tool rather than a source of complications for sleep apnoea patients. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories